Assessment of apathy in neurological patients using the Apathy Motivation Index caregiver version.
Level 4 - case-series / case-control
Cross-sectional scale development and psychometric validation study across clinical cohorts.
PubMed 34532963 · doi:10.1111/jnp.12262
What was done
Researchers developed and validated a brief caregiver questionnaire version of the Apathy Motivation Index (AMI-CG) to evaluate multidimensional apathy across three domains: Behavioural Activation, Emotional Sensitivity, and Social Motivation. The instrument was tested across four neurological populations—Parkinson's disease, Alzheimer's disease, subjective cognitive impairment, and limbic encephalitis—and compared against the Lille Apathy Rating Scale, patient self-reports, and measures of depression, anhedonia, cognition, activities of daily living, and caregiver burden.
What was found
The abstract reports no numerical values, sample sizes, or test statistics. The authors report that the three-factor structure was confirmed, with the scale demonstrating good internal reliability, external validity, and diagnostic accuracy. The tool detected cases of social apathy missed by standard instruments, and patients who underestimated their apathy relative to caregiver reports had greater impairment in activities of daily living and higher caregiver burden.
Why it matters
The AMI-CG offers a rapid, multidimensional caregiver-reported metric for evaluating apathy in neurological patients who may lack insight, overcoming time constraints associated with comprehensive clinical interviews.
Limits
The abstract does not disclose sample sizes, demographic characteristics, or quantitative psychometric values (such as sensitivity, specificity, or correlation coefficients). Long-term test-retest reliability and longitudinal responsiveness to disease progression or intervention were not reported.
Cited by
- supports Apathy dissociates into distinct clinical subdomains, including behavioral, social, emotional, and cognitive apathy.